Vimarsana
Biggest News Aggregation in the World

Page 12 - Psychiatric Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Psychiatric Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Psychiatric Sciences Today - Breaking & Trending Today

Harsh discipline may cause lasting mental health problems in kids: Study - Vimarsana News

Harsh discipline may cause lasting mental health problems in kids: Study

Do you often shout at your kids or isolate them when they misbehave? If so, your kids are more likely at risk of developing lasting mental health problems, according to a new study.The study of over 7,500 Irish children, reported in the journal ...

Kids Likely To Develop Mental Health Problems Due To Harsh Discipline: Study - Vimarsana News

Kids Likely To Develop Mental Health Problems Due To Harsh Discipline: Study

The study reveals children's mental health is shaped by multiple risk factors, including gender, physical health, and socio-economic status.

Source: india.com
Investegate |COMPASS Pathways Announcements | COMPASS Pathways: COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP - Vimarsana News

Investegate |COMPASS Pathways Announcements | COMPASS Pathways: COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP

Investegate announcements from COMPASS Pathways, COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP

Mental health support for children and young people lacking in low and middle-income countries - SOS Children's Villages International - Vimarsana News

Mental health support for children and young people lacking in low and middle-income countries - SOS Children's Villages International

Mental health experts at SOS Children’s Villages call for adopting strategies to improve mental health support for all children.

COMPASS Pathways announces publication of phase 2b study of - Vimarsana News

COMPASS Pathways announces publication of phase 2b study of

After a single 25mg dose of COMP360 psilocybin therapy, approximately 30% of patients with treatment-resistant depression (TRD) were in remission at...